SGLT2 inhibitors in chronic kidney disease: cardiorenal outcomes, safety, and implementation in primary care
Background: Chronic kidney disease (CKD) is linked to high cardiovascular morbidity and mortality. Many patients remain at risk despite standard treatment. This review assessed the renal, cardiovascular, safety, and primary care implementation outcomes of sodium-glucose cotransporter-2 (SGLT2) inhibitors in CKD, includ...